Kohn, A <br/><br/>
Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients.  [electronic resource] 

 -  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver  Sep 2002 
 - 626-30 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1590-8658 
<br/><br/><label>Standard No.: </label>10.1016/s1590-8658(02)80204-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Antineutrophil Cytoplasmic--blood<br/>Antibodies, Monoclonal--therapeutic use<br/>C-Reactive Protein--analysis<br/>Child<br/>Colitis, Ulcerative--blood<br/>Female<br/>Gastrointestinal Agents--therapeutic use<br/>Humans<br/>Infliximab<br/>Male<br/>Methylprednisolone--therapeutic use<br/>Middle Aged<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors